Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IP Paclitaxel + XELOX for Conversion Surgery in Gastric Cancer
NCT04797923Phase 2Unknown
- Sponsor
- Gangnam Severance Hospital
- Start
- Dec 2019
- Primary completion
- Jun 2021
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection in gastric cancer (GC), sponsored by Gangnam Severance Hospital. Status: unknown.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT04797923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04797923.